Wursthorn Karsten, Manns Michael P, Wedemeyer Heiner
Clinic for Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Best Pract Res Clin Gastroenterol. 2008;22(6):1063-79. doi: 10.1016/j.bpg.2008.11.006.
Chronic hepatitis B and hepatitis C virus infections are the major causes of liver disease, hepatocellular carcinoma (HCC) and liver-related mortality worldwide. Among factors known to influence the natural history of viral hepatitis are age at the time of infection, duration of infection, serum alanine aminotransferase (ALT) levels, male sex, alcohol consumption, and coinfections. In hepatitis B, serum HBV DNA concentration emerges as the key factor for predicting the development of liver disease. Even patients with low viraemia seem at increased risk for liver cirrhosis and HCC. Coinfections with hepatitis C, hepatitis D and/or HIV are common and are associated with a more severe liver disease. The course of chronic hepatitis C is variable, but usually fibrosis advances slowly. In addition to the better-known factors- including coinfections with HBV and HIV- progression of liver disease is adversely affected by smoking, hepatic steatosis and insulin resistance.
慢性乙型肝炎和丙型肝炎病毒感染是全球范围内肝脏疾病、肝细胞癌(HCC)及肝脏相关死亡的主要原因。已知影响病毒性肝炎自然史的因素包括感染时的年龄、感染持续时间、血清丙氨酸氨基转移酶(ALT)水平、男性、饮酒及合并感染。在乙型肝炎中,血清HBV DNA浓度成为预测肝脏疾病发展的关键因素。即使是低病毒血症患者,发生肝硬化和HCC的风险似乎也会增加。与丙型肝炎、丁型肝炎和/或HIV的合并感染很常见,且与更严重的肝脏疾病相关。慢性丙型肝炎的病程多变,但通常纤维化进展缓慢。除了包括与HBV和HIV合并感染等更为人熟知的因素外,吸烟、肝脂肪变性和胰岛素抵抗也会对肝脏疾病的进展产生不利影响。